Retatrutide at the 12 mg dose produced nausea in 38-43% of Phase 3 trial participants
And I was like, I dont want to die overweight and unhappy. And so I just decided to weather it. The interviews also suggested many patients were not necessarily getting the kind of detailed, ongoing guidance that could help them manage or expect those symptoms
Tanguturi Yella SS, Kota Sesha Brahma Sree KS, Mahato SK (2025) The Role of Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Alcohol Use Disorder: Current Evidence and Future Directions
While very high oral doses (1,000 to 2,000 mcg) can achieve some passive absorption without intrinsic factor roughly 1% of the dose is absorbed passively many clinicians prefer the reliability and rapid correction offered by injections in this population
Jain SK, Parsanathan R, Achari AE, Kanikarla-Marie P, Bocchini JA Jr
This has significant implications for these patients who delay seeking help for their complaints, running the risk of those complaints becoming more serious or even permanent
